538 related articles for article (PubMed ID: 32142359)
1. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
[TBL] [Abstract][Full Text] [Related]
3. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
[TBL] [Abstract][Full Text] [Related]
5. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
7. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
[TBL] [Abstract][Full Text] [Related]
8. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.
Meloni M; Descamps B; Caporali A; Zentilin L; Floris I; Giacca M; Emanueli C
Diabetes; 2012 Jan; 61(1):229-40. PubMed ID: 22187379
[TBL] [Abstract][Full Text] [Related]
10. A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.
Velagic A; Li M; Deo M; Li JC; Kiriazis H; Donner DG; Anderson D; De Blasio MJ; Woodman OL; Kemp-Harper BK; Qin CX; Ritchie RH
Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H241-H257. PubMed ID: 36607798
[TBL] [Abstract][Full Text] [Related]
11. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.
Bernardo BC; Weeks KL; Pongsukwechkul T; Gao X; Kiriazis H; Cemerlang N; Boey EJH; Tham YK; Johnson CJ; Qian H; Du XJ; Gregorevic P; McMullen JR
Clin Sci (Lond); 2018 Feb; 132(3):381-397. PubMed ID: 29358507
[TBL] [Abstract][Full Text] [Related]
13. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
15. A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology.
Weeks KL; Kiriazis H; Wadley GD; Masterman EI; Sergienko NM; Raaijmakers AJA; Trewin AJ; Harmawan CA; Yildiz GS; Liu Y; Drew BG; Gregorevic P; Delbridge LMD; McMullen JR; Bernardo BC
J Mol Med (Berl); 2024 Jan; 102(1):95-111. PubMed ID: 37987775
[TBL] [Abstract][Full Text] [Related]
16. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
Lei L; Hu H; Lei Y; Feng J
Biochem Biophys Res Commun; 2018 Nov; 506(3):668-673. PubMed ID: 30454704
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
Ansari M; Gopalakrishnan S; Kurian GA
J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats.
Liu XY; Liu FC; Deng CY; Zhang MZ; Yang M; Xiao DZ; Lin QX; Cai ST; Kuang SJ; Chen J; Chen SX; Zhu JN; Yang H; Rao F; Fu YH; Yu XY
BMC Cardiovasc Disord; 2016 Feb; 16():41. PubMed ID: 26879576
[TBL] [Abstract][Full Text] [Related]
19. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
[TBL] [Abstract][Full Text] [Related]
20. AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models.
Zhong P; Peng J; Liu T; Ding HS
Cardiovasc Toxicol; 2022 Jan; 22(1):88-96. PubMed ID: 34674150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
